# Adjuvant Quisinostat in High-Risk Uveal Melanoma

> **NCT06932757** · PHASE2 · RECRUITING · sponsor: **University of Miami** · enrollment: 63 (estimated)

## Conditions studied

- Uveal Melanoma

## Interventions

- **DRUG:** Quisinostat

## Key facts

- **NCT ID:** NCT06932757
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-27
- **Primary completion:** 2030-05-27
- **Final completion:** 2030-05-27
- **Target enrollment:** 63 (ESTIMATED)
- **Last updated:** 2025-06-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06932757

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06932757, "Adjuvant Quisinostat in High-Risk Uveal Melanoma". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06932757. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*